CATHERINE POULOS: Open Payments
NPI 1396997672 · HAMPTON BAYS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 27 payments from 14 companies in 2025. Trend: 2023 $1,454 · 2024 $1,121 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $156 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| ABBVIE INC. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| Corium, LLC | 2 | $35 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Qelbree, HETLIOZ, COBENFY, REXULTI, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
